Similar downregulation of PXN by Diphenyleneiodonium for the treatment of stroke has been also documented (Nagel et al., 2012) although experimental evidence describing functional pathways of PXN involvement in stroke pathology is scarce. Here, PXN is linked to stroke disorder.